Praxis Precision Medicines (PRAX) Accumulated Depreciation & Amortization (2022 - 2025)
Praxis Precision Medicines (PRAX) has 4 years of Accumulated Depreciation & Amortization data on record, last reported at $1.5 million in Q4 2025.
- For Q4 2025, Accumulated Depreciation & Amortization rose 10.2% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, up 10.2%, while the annual FY2025 figure was $1.5 million, 10.2% up from the prior year.
- Accumulated Depreciation & Amortization reached $1.5 million in Q4 2025 per PRAX's latest filing, up from $1.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $1.5 million in Q4 2025 and bottomed at $572000.0 in Q4 2022.
- Average Accumulated Depreciation & Amortization over 4 years is $1.1 million, with a median of $1.2 million recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: soared 75.7% in 2023, then grew 10.2% in 2025.
- A 4-year view of Accumulated Depreciation & Amortization shows it stood at $572000.0 in 2022, then skyrocketed by 75.7% to $1.0 million in 2023, then skyrocketed by 35.62% to $1.4 million in 2024, then increased by 10.2% to $1.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $1.5 million in Q4 2025, $1.4 million in Q4 2024, and $1.0 million in Q4 2023.